Shore Operating Partners bridge the financial expertise of Shore investment professionals with the operating and strategic needs of our portfolio companies. Shore Operating Partners represent leaders of their respective fields and facilitate the implementation of value creation strategies through past experience and a deep network of industry relationships.
Kush Agarwal currently serves as a board member and strategic advisor of Vein Clinics of America after serving as President and CEO for over 20 years. Kush also serves as a member of the Board of Directors of United Vision Partners, a private equity backed multi-site ophthalmology platform based in Minnesota. During his time as CEO, Vein Clinics of America grew from 3 centers to over 25 centers across 10 states. In addition, Mr. Agarwal served on the board of directors of IntegraMed America upon their acquisition of Vein Clinics of America in August 2007.
Mark is an Adjunct Associate Professor of Entrepreneurship at the University of Chicago Booth School of Business. Prior to being a Professor at the University of Chicago Booth School of Business, Mark served as the President and CEO of Lou Malnati’s Pizzeria.
Hilarie Aitken is the CEO and Co-Owner at Navia Benefits Solutions and has been an integral part of the vision and growth of Navia for over 20 years. Her passion and expertise in the field have been a driving force in the expansion of consumer driven employee benefits throughout the region.
Jim currently serves on the Board of Directors of Community Care Partners. Jim is currently the Chief Operating Officer at Banfield Pet Hospitals, a nationwide provider of general veterinary services. Prior to his current position at Banfield, Jim served as President and CEO of CareMeridian, where he oversaw nursing and rehabilitative facilities. Jim draws from a deep background comprising of multi-site healthcare, business development, and data analytics.
Michael currently serves on the Board of Directors of Mission Veterinary Partners, Golden Bear Therapy Partners, and Together Women's Health, Shore Capital portfolio companies. Michael is a co-founder of MD Holdings, an entrepreneur-owned holding company formed to acquire and grow a limited number of businesses with significant growth potential. From 2015—2017, Mr. Aubrey was Chief Executive Officer of StatLab Medical Products and successfully led the company through its sale to Cressey & Company. Prior to being appointed CEO, Michael served as Co-President of StatLab Medical Products from 2009 to 2015, where he had oversight of the company’s sales, marketing, product development, and technical support capabilities. Under Michael’s leadership, StatLab’s equity value increased 10x+ and the Company established itself as the premier anatomic pathology supplier in the United States. Prior to acquiring StatLab Medical Products, Michael was CEO of a parking lot facility management company where he grew facility revenues under management from $3 million to $20 million and headcount from 25 to 125 in less than five years. Michael also sits on the Boards of StatLab Medical Products, MedCerts, LLC., and Delasco Dermatological Supply Company.
Tom Bailey is a board member of SCP Interventional Radiology, a realized Shore portfolio company. Tom joined NanoString Technologies as CFO in January 2018. He was formerly the CFO of Agamatrix and previously served as President and CEO for Angiotech Pharmaceuticals, Inc. until the fall of 2013, at which time he transitioned to Angiotech’s board. As CEO of Angiotech, Tom led the company through a successful operational restructuring, and concluded the sale of one of Angiotech’s two medical device products businesses, generating significant returns for Angiotech’s shareholders. Prior to being named Angiotech’s CEO in the fall of 2011, Tom served for six years as Angiotech’s CFO, and for two years as its Vice President of Business Development. Prior to Angiotech, Tom worked as an investment banker in the life sciences practice group at Credit Suisse First Boston and Donaldson, Lufkin & Jenrette.
Nate Bard serves as CEO of Triumph Orthopedics, Shore Capital’s orthopedic services platform investment, and as a Board Member for Column Health, Shore Capital's second medication-assisted treatment platform investment. Most recently, Nate previously lead ATI Physical Therapy’s (“ATI”) growth function, serving as its Chief Growth Officer. In this role, he was responsible for sales, marketing, mergers, acquisitions, and new clinic growth and openings. Nate joined ATI in 2014, bringing a background in private equity and investment banking experience. Originally from Michigan, Bard is a graduate of the University of Notre Dame with a degree in Finance. With a combination of strategic and financial expertise, Nate has helped ATI expand its acquisition capabilities with an analytical approach to decision making.
David Barr is a Board of Directors Member at Column Health, Shore Capital's second medication-assisted treatment platform investment. David currently serves as Chairman of PMTD Restaurants as well as Managing Director of Franworth, a professional services firm for and investor in franchise businesses. In connection with IFA, Barr has met with the White House, senators, congressmen and their staffs to discuss the impact of ACA on restaurant jobs. In addition, Barr has spoken about healthcare on Fox News, Fox & Friends, CNN Online, and his experiences have been written about by New York Times, International Business Times, and the Washington Examiner. David is the former Chairman of the International Franchise Association and has significant experience in opening retail locations through his involvement with Del Frisco’s Restaurant Group, Capriotti’s Sandwich Shops, Mrs. Fields and TCBY, the Jewelry Group, Pizza Hut, and several other consumer-retail businesses. David Barr began his career in Atlanta with Pricewaterhouse Coopers after attending the University of Virginia.
Dylan Bates currently serves on the Southern Veterinary Partners Board of Directors. Dylan is the Chief Executive Officer and President of ATI Physical Therapy Holdings, LLC (“ATI”) and also sits on ATI’s Board of Directors. Dylan joined ATI in 1999 to expand physical therapy services and has seen the company grow from 1 location in Illinois to nearly 300 locations across 10 states. ATI has undergone three private equity investments. It was initially bought by KRG Capital, a Denver-based private equity firm, in 2005, then sold to GTCR, a Chicago-based private equity firm in March 2010, and then repurchased by KRG in December 2012. Dylan is a licensed Physical Therapist with extensive experience in multi-site healthcare services and operations.
Casey has over 19 years of proven success across various operational functions and has provided significant operational cost savings and working capital improvements to over 10 one billion+ dollar revenue organizations through use of enterprise lean and six sigma methodologies.
George has over 30 years of experience in the packaging industry and has served in several roles over his career. George currently serves as a principal at Whitehall Investors and CEO Advisory Group. George’s prior experience includes roles as Co-Chairman of U.S. Can Corporation, Chairman and Chief Executive Officer of Altivity Packaging, and Chief Executive Officer of Ivex Packaging.
Greg Bell is the founder and CEO of Expansion Health, a technology to help health systems deliver multiple digital patient services into a single mobile app. Greg has over 35+ years building successful businesses in healthcare. Prior to Expansion Health, he founded HealthX, one of the first cloud-based technology companies in healthcare, and grew the business to the largest healthcare portal provider for U.S. health plans and payors. Prior, Greg also founded First Benefit Corp in 1982 and grew the company to one of the largest TPAs in the country in five years. Greg has a reputation for building solid teams that deliver exceptional healthcare services.
Dave has forty years of experience in food & beverage and CPG. Dave began his career at Procter & Gamble where he spent twenty-four years in product supply and supply chain management. In 2005 he joined the Campbell Soup Company where he served in several key supply chain leadership roles prior to assuming responsibility for the company’s global supply chain. Currently, Dave serves as Conagra’s Chief Supply Chain Officer, a role in which he has helped drive efficiencies and growth since 2015. Dave has end-to-end supply chain responsibilities for the company, overseeing manufacturing, procurement, engineering, environmental sustainability, health and safety, plant quality, customer logistics and planning, transportation and warehousing, and aviation and real estate/facilities teams. Dave is also a member of the board of directors for Ardent Mills, a Conagra Brands joint venture and also serves on the board for World Business Chicago.
Marcy A. Bliss, CEO and Board member of PE-owned Wedgewood Pharmacy, is responsible for all aspects of the pharmacy operation and for leading the delivery of extraordinary business results.
Dan Bowen is a board member of Argentum Medical, a Shore Capital portfolio company. Dan founded Dempsey Ventures, an investment firm funded by his personal capital and focused on medical products, in 2006 and serves as its Chief Executive Officer. Prior to Dempsey Ventures, he served as the President and Chief Executive Officer of Aspen Surgical. In 1999, Dan formed Aspen Surgical Products and purchased a few single-use surgical product lines from a public company. He grew that business over ten-fold and sold a majority interest to RoundTable Healthcare Partners in 2006. He began his career in the healthcare industry at Baxter Healthcare working in several positions and eventually leaving it after serving as a regional sales manager and corporate account executive.
Scott currently serves on the Board of Directors of Mission Veterinary Partners. Scott is currently Chief Executive Officer of Forefront Dermatology, a sponsor-backed, leading multi-state, multi-location dermatology group practice. Prior to his role at Forefront, Scott was President and Chief Operating Officer of Interdent, a dental practice management company, where his responsibilities ranged across practice operations, marketing, recruiting, acquisitions, office development and purchasing. Scott draws from a deep background comprising of multi-location operations, McKinsey consulting, Disney business development, and middle market private equity.
Michael is an entrepreneur, investor and healthcare strategist with 30 years’ experience leading technology-enabled healthcare organizations.
Diana Cantor currently serves on the Board of Directors of Strongpoint Partners . Diana is a Partner at AIM13, an alternative investment management firm where she acts as a member of the Investment Committee and Board of Managers. Prior to joining AIM13, she was a Managing Director at New York Private Bank & Trust and served for over a decade as the founding Executive Director of the Virginia College Savings Plan, which she grew into the largest 529 savings plan in the nation. Prior to her state service, Diana was a Vice President at Goldman Sachs, where she served as Chief Administrator of the firm’s leveraged buyout funds, internal investment funds, and merchant banking operations. Diana began her career as a lawyer in the real estate department of Kaye Scholer (now Arnold & Porter).
Bob is an accomplished healthcare and technology executive with thirty years of experience building and managing organizations to deliver long-term revenue and profit growth. He has lead or played a key role on multiple executive teams that successfully translated market needs into corporate strategy and then executed on the product, sales, marketing and client support initiatives needed to drive quantifiable business success. Bob’s key leadership experiences include working as a Manager at IBM in various marketing and sales roles in the 80's and 90's. He served in multiple executive positions at Healthx from 1999 to 2016. Healthx delivers a cloud-based Software as a Service platform serving the healthcare payer and TPA market delivering member and provider engagement solutions to drive efficiency and collaboration between health plans, providers and consumers. Bob was the Chief Growth Officer at ELAP Services, a solution provider to self-insured employers providing price transparency solutions. He has worked at High Alpha, a SaaS Venture Capital firm, in one of their portfolio companies Doxly that is focused on automating M&A transactions for large law firms. He now leads the growth strategy at Beyond Payroll, an analytics company focused on the Human Capital Management space. Bob received a Bachelor of Science in Quantitative Business Analysis from Indiana University – Kelley School of Business.
Angela currently serves on the Board of Directors of Elevate Women’s Health. Angela is currently the Executive Director of Lexington Eye Associates, a physician-owned ophthalmology group based in the Boston Area. Previously, Angela served as the CEO of Northeast Dermatology Associates, one of the largest physician-owned dermatology practices in the United States and the market leader in the New England region with 15 clinical locations and more than 35 providers across Maine, Massachusetts, and New Hampshire. Prior to Northeast, Angela was a Vice President of Operations at The Dermatology Group.
Jon Clark currently serves as SVP at Danaher Company, which designs, manufactures, and markets professional and medical products.
Bill Clendenen currently serves on the Board of Directors of Navia Benefit Solutions, Community Care Partners, Elevate Women’s Health, Together Women's Health, and Innovative Packaging Company.
Tom currently serves on the Board of Directors and as Lead Independent Director of Assembly Health. Tom is currently the Chairman of Hanger Inc., as well a Board Member at Kindred Healthcare, a provider of hospital, home health, rehabilitation, and hospice services. Prior to his role at Hanger, Tom founded Spectrum Emergency Care, a national emergency physician company. Tom draws from a deep background comprising of multi-location operations, hospital operations, mental health services operations, and medical product distribution.
Matt currently serves as a Group Vice President of Retail Operations at Meijer and has held a variety of executive management positions with the company since 2009. Prior to joining Meijer, Matt served as Vice President of Operations at Lotus Supercenters where he was responsible for creating and implementing standard operating procedures and training plans for 32,000 associates in mainland China. Before joining Lotus, Matt served in several corporate and store level leadership positions at Wal-Mart from 1999-2007. Matt currently sits on the University of San Diego Engineering School Board of Directors.
Jan Creidenberg serves as Lead Independent Director and board member of Argentum Medical, as well as board member of Innovia Medical, two of Shore Capital's portfolio companies. He most recently served as Vice President, General Manager for the Infection Prevention business of CareFusion, Inc. a global medical technology company. Jan was responsible for leading marketing initiatives in the U.S. and internationally, including currently marketed products, market research, and commercial development of new products. Jan has over 20 years of domestic and international marketing and communications experience in pharmaceuticals, healthcare and consumer brands. Jan joined Carefusion following the acquisition of Enturia Inc. where he led all aspects of marketing to successfully commercialize ChloraPrep® and related products in markets outside the United States.
Jim Cunniff is the President and CEO of Provista, a group purchasing organization. Jim has held a wide range of operating roles throughout his career; he previously served as President and CEO of Leiter’s Compounding, an outsourced pharmaceutical company, and Senior Vice President of the Americas for Acelity, a global advanced wound care company. Jim also worked at Stryker for over a decade, including as President of Stryker’s Emerging Markets, Pacific, South Pacific, and Medical Divisions. Jim began his career in management roles at Berkshire Corporation, Smiths Medical, and Baxter International.
Tim Danison is a co-founder and current CEO of Tabula Health. Tabula is a financial services organization focused on healthcare and reinventing the financial relationship between healthcare providers and their patients. Prior to Tabula Health, Tim was an entrepreneur and executive in various Saas/enterprise software and technology-enabled service companies. Tim has been an early-stage employee and co-founder of multiple companies throughout his career. Tim has expertise in various stages of growth including capital raising, new product development, client services realignment and organizational scaling, sales management, professional services delivery, and mergers & acquisitions. Significant and successful track record in bringing new products and services to market and creating reference clients and partner channel opportunities. From 2000 – 2007 Tim served as a Founding Member and senior executive at WageWorks (NYSE: WAGE), a leading provider of consumer directed health, commuter & employee benefit plans in the U.S.
Dr. Bob DeCresce currently serves on the Board of Directors of BrightView and Elevate Women’s Health, Shore Capital's medication-assisted treatment and women’s health platform investments, respectively. Bob was also a member of the Board of Directors of ClearPath Diagnostics, a former Shore laboratory services portfolio company serving the women’s health industry. Bob has been Director of Clinical Laboratories at Rush University Medical Center since 1991 and serves as Chairman of the Department of Pathology at Rush Medical College in Chicago. In addition to serving on multiple lab company boards, Bob is a Director for VWR a worldwide distributor of scientific equipment and supplies with $4 billion in global sales.
Todd currently serves on the Board of Directors of Southern Veterinary Partners. Todd currently serves as President of Clear Choice Dental Implants, the largest dental implant company in the United States. Clear Choice is a twice Private Equity-backed business, first by L Catterton and then acquired by Sun Capital. Prior to his time at Clear Choice, Todd was President and CEO of Pong Research Corporation, an L Catterton backed mobile technology business.
hil Douglas is a seasoned leader who has management and board experience which spans diverse organizational settings and industries. Phil is skilled in recruiting, organizing and leading management teams to create and enhance shareholder value. His experience includes operations, restructuring, governance, marketing, finance, mergers and acquisitions, strategic and financial planning, accounting, treasury, human resources, venture capital and information technology. Phil currently serves on the Board of Directors of Oceans Healthcare, Ernest Healthcare and Breath Diagnostics. Oceans Healthcare provides inpatient and outpatient behavioral healthcare services in Texas, Louisiana and Mississippi. Ernest Healthcare is a leading provider of post-acute services. Breath Diagnostics is focused on the early detection of lung cancer through the use of its innovative and proprietary breath analysis technology. From January 2018 until August 2019 Mr. Douglas served as a Board Member and Executive Chairman of KureSmart Pain Management. The Company which is a leading provider of interventional pain management services in the Mid-Atlantic region was sold by New Harbor Capital to Nexphase Capital in August 2019.
Andy has over 20 years of experience in the flavor and ingredient industry and has worked with and developed products for some of the largest companies in the food and beverage space. Andy joined Imbibe, a beverage innovation firm, eleven years ago and serves as EVP and Chief Commercial Officer.
Kevin has over 30 years of experience in the flavor, ingredient, and broader food and beverage industry and has been a C-suite executive across many firms of varying sizes.
Dino Eliopoulos currently serves on the Board of Directors of both Southern Veterinary Partners and Community Care Partners, and has more than 20 years of experience leading healthcare organizations. Dino is currently the Chief Executive Officer of Behavioral Innovations, one of Shore Capital's current platform investments in the autism services sector. Most recently, he was a senior vice president and Chief Financial Officer of Provista, a leading healthcare-focused performance improvement company. Prior to his role at Provista, Dino was the Chief Financial Officer of MedExpress, a multi-state urgent care company. At MedExpress, Dino expanded the company from a 4 clinic operation into to 60+ clinics with over $180 million in revenue. He was responsible for overseeing real estate activities at MedExpress, including site selection and build-out of final 40 clinics. Prior to MedExpress, Dino held various executive leadership positions with PricewaterhouseCoopers, Access Plans USA, Trinity Hospice, and Precis.
Dr. Genevieve Fairbrother, is a practicing physician and currently serves as the Chief Medical Officer of Atlanta Women’s Health Group, the parent organization for a consortium of women’s health practices in the Atlanta area, representing more than 100 physicians and 40 certified nurse midwives through over 40 locations in the Atlanta area.
Chris Fashek is a member of the Board of Directors of Argentum Medical, a Shore Capital portfolio company.
Andrea Feirstein currently serves on the Board of Directors of Strongpoint Partners . Andrea is the founder and CEO of AKF Consulting Group, an SEC and MSRB-registered municipal advisor, where she has advised more than forty public administrators on strategic aspects of State-run Investment Plans.
Jim Fitzgerald is a board member of Argentum Medical, a Shore Capital portfolio company. Jim is the founder and former President and CEO of HealthTrust Purchasing Group where he oversaw its initial formation in 1999, its financial and operational functions and managed the contracting for clinical supplies, pharmaceuticals, and capital equipment, totaling approximately $20 billion annually. Jim has over 30 years of healthcare operations and leadership experience. Prior to founding HealthTrust, he served as President of HCA's Supply Chain Services, as well as several other leadership roles within HCA.
James E. Forrest currently serves as Chairman of Shore Capital, a Chicago-based private equity group focused on health care services and the food industry
Randy currently serves on the Board of Directors for Golden Bear Therapy Partners, a Shore Capital portfolio company. Randy is also the President & Co-Founder of Revolution PT and Weight Loss, based in Chicago. He founded and served as the CEO of Accelerated Rehab Centers, until the sale of Accelerated to Gryphon Investors (Accelerated would later become part of Athletico). He previously served in the Peace Corps in Bogota, Columbia.
Dr. Eugene Gabianelli, a board-certified, highly respected ophthalmologist, has practiced in Atlanta since 1992, and founded Georgia Eye Partners in 1999. His primary areas of focus are LASIK, cataract and corneal transplantation surgery. His LASIK experience began in 1995 as a co-investigator for the Summit Omnimed laser. He has extensive experience with the Nidek, Visx and Wavelight Allegretto Lasik platforms. His combined Lasik and refractive cataract surgical experience totals over 30,000 procedures. His refractive cataract practice includes all varieties of intraocular lens technology including specialty multifocal and toric lenses coupled with femtosecond laser cataract surgery. He is also active in laser vision correction following cataract surgery and corneal transplantation.
Susan has over 30 years of experience in broader food and beverage industry and has been a C-suite executive across many firms of varying sizes.
Mike George currently serves on the ClearPath Diagnostics Board of Directors. From 1998 to 2001, Mike served as the President, COO and CEO of UroCor, Inc. a 430 employee laboratory that specialized in oncology products and services for Urologists. Prior to Mike’s arrival, the company struggled to grow, was consistently unprofitable and was embroiled in a Department of Justice investigation into Medicare Fraud and Abuse. Mike successfully negotiated a settlement with the Department of Justice and returned the company to profitable growth. During Mike’s tenure the company increased revenue by 50% to $60 million and saw the stock price appreciate more than 600% with market capitalization growing from $28 million to $190 million. In addition to driving rapid growth, Mike successfully installed infrastructure and financial discipline to ensure continued revenue and earnings growth. In 2001, the company was sold to DIANON.
Joseph Giles is currently on the Board of Directors of Transformations Care Network. He previously sat on the Board of Directors for Florida Autism Center, a realized Shore portfolio company.
Bing has over 35 years of experience in the dairy and broader food & beverage industries and has extensive functional background in operations and sales management. Previously, Bing was a Chairman and CEO of Fairmount Food Group (DCI Cheese), a PE-backed specialty cheese platform that was sold to Saputo in 2011.
Sean has over 30 years of experience in the large-scale retail food distribution industry. Previously, Sean served as the Chief Operating Officer of United Natural Foods, Inc. (U.N.F.I.). In his role as COO, Sean was responsible for U.N.F.I.’s sales, services, operations, merchandising and retail functions.
Dr. Richard Hawkins is a co-founder of the Steadman Hawkins Clinic and serves as the Chairman of the Hawkins foundation.
Jim Heath is the former Executive Vice President of Customer Excellence and Chief Operating Officer at Flexfab, a silicone manufacturer. Prior to joining Flexfab, Jim worked at Stryker for over 25 years in a range of positions including President of Stryker Instruments, Vice President and General Manager of Stryker Surgical, and Vice President of Sales of Stryker Instruments and Stryker Medical.
Mr. Edgar F. Heizer, III, also known as Skip, currently serves as Chairman and Managing Member of Heizer Capital LLC and as an Executive Chairman of two businesses that were founded by Heizer Capital and its affiliates: LB Limited of Hamilton, Bermuda, and Trinchera Production Company. In addition, Mr. Heizer serves as an Advisory Partner of Tyree & D’Angelo Partners.
Brad has over 30 years’ experience in various management roles in the food, beverage and packaging sectors. Brad is the Founder and Principal at 21 Elephants LLC, an independent advisory firm providing corporate strategy, M&A, and operational improvement services. Prior to 21 Elephants, Brad led Amcor’s North American Flexible Packaging Business. His Amcor tenure also includes global leadership roles as Vice President of Corporate Development & Strategy, Director of Strategic Marketing and Director of Acquisitions and Integration and Global Director of Medical Products. Prior to his tenure at Amcor, Brad was a Senior Management Consultant within the Strategy and Process Improvement Practice at Arthur D. Little. He also served as the Global Category & Key Account Director of Beverage at Graphic Packaging International.
Phil is a national behavioral healthcare expert with over 45 years of experience. He is a featured speaker on clinical excellence and addiction treatment with keynote and panel conference presentations for the West Coast Symposium of Addiction Disorders, the National Association of Addiction Treatment Providers (NAATP), Moment of Change, and the CRC Health Group Professional Development Workshop. Most recently, Phil served as Chief Clinical Officer for CRC Health Group where he was responsible for the measurement and improvement of clinical services and the research and development of new treatment technologies. Specifically, Phil oversaw all MAT activities at CRC which was the nation’s largest provider of MAT services prior to the sale to Acadia. He also oversaw the CRC Clinical Advisory Board of distinguished healthcare industry experts. Before joining CRC in 2002, Phil served as Chief Executive Officer of Behavioral Health Concepts, a national mental health management company that he founded in 1993. He also spent eight years with Republic/OrNda Health Corporation where he developed and managed free-standing psychiatric and substance abuse treatment hospitals. Phil began his career as a Clinical Psychologist in Southern California where he practiced for 10 years.
Terry currently serves on the Board of Directors of EyeSouth Partners, a realized Shore portfolio company, and OMS360, a Shore Capital Portfolio company. Terry is the Managing Partner of Northwood Healthcare Partners, a healthcare private investment firm based in Washington, D.C. Previously, Terry served as a Managing Director of Flexpoint Ford, an industry focused private equity firm specializing in healthcare and financial services. Terry has worked with healthcare companies for 30 years, including companies in almost every sub-segment of healthcare services, including significant experience with physician practice management companies and ASCs. Terry began his career in investment banking and worked in the business for over 19 years. During his career in investment banking, Terry led the healthcare M&A business for Credit Suisse and successfully advised companies on over $20 billion of transactions.
John has extensive executive leadership experience serving the restaurant, retail, distribution and amusement park industries. John served the Wendy’s system for over 11 years, leading the launch of Wendy’s Quality Supply Chain Cooperative in January 2010, which manages over $4 billion in spend annually for Wendy’s restaurants. John’s range of executive experience - including supply chain, distribution, procurement, and operations - gives him powerful insight into every link of the foodservice industry and a keen understanding of the trends impacting the channel. Prior to joining Wendy’s QSCC, John served in the manufacturing and distribution sector as Executive Vice President and General Manager for the Commercial Division of Nice-Pak/PDI, the global expert in preventing infection and cross-contamination from bacteria in foodservice and healthcare settings. John also served as Chief Procurement Officer of U.S. Foodservice as well as Senior Vice President of Purchasing, Distribution, and Logistics for Unified Foodservice Purchasing Co-op, LLC (the co-op for Yum! Brands), where he oversaw the procurement and distribution interests of franchise and corporate stores across A&W, KFC, Long John Silver’s, Pizza Hut, and Taco Bell. John is a former member of the board of the Dave Thomas Foundation for Adoption. John previously chaired the Supply Chain Committee of the National Council of Chain Restaurants, and served on other various trade association Board and committees supporting the restaurant industry. He currently serves as Chairman of the Board for GS1 US, and is a member of the global Board for GS1.
Jason has over 20 years of experience in the protein distribution industry. Previously, Jason served as the President and CFO of Sherwood Food Distributors prior to the merger with Harvest in 2017, when he became Co-President of Harvest Sherwood through 2019.
Joel has over 25 years of experience in the large-scale retail food distribution industry. Previously, Joel served as the Executive Vice President of Operations Sherwood Food Distributors prior to the merger with Harvest in 2017, when he became Co-President of Harvest Sherwood through 2019.
Bill Jasien currently serves on the Board of Directors of Strongpoint Partners . Bill is the CEO and Managing Director of StoneHedge Global Partners, an alternative investment firm. Bill has direct experience in retirement services.
Kevin Johnson previously sat on the Board of Directors for ClearPath Diagnostics, a realized Shore portfolio company. He has over 26 years of experience in the lab diagnostics industry. From 1996 until 2003, Kevin served as Chairman, Chief Executive Officer and President of DIANON Systems, Inc., a publicly-traded cancer diagnostic services company. During that time, DIANON grew annual revenues from approximately $56 million to approximately $200 million, and the company's market capitalization grew from $45 million to approximately $600 million when it was sold to Laboratory Corporation of America (NYSE: LH) in January of 2003. Prior to joining DIANON, Mr. Johnson was employed by Quest Diagnostics and Quest's predecessor, the Life Sciences Division of Corning, Inc., for 18 years, and held numerous management and executive level positions.
Lee Kaplan is a board member at Point C, a Shore Capital portfolio company. Lee began his career as a CPA working For Ernst and Whinney in Los Angeles. In 1985 he joined Enterprise Holdings, Inc. Enterprise operates Enterprise Rent-A-Car, Alamo Rent-A-Car, National Car Rental, Enterprise Fleet Services, and Enterprise Truck Rental through a network of 9,600 corporate and franchised locations and over 2 million vehicles throughout the world. Over his 33-year career Lee held positions as Vice-President of Finance, Corporate Risk Officer, and Chief Administrative Officer. While overseeing the Company’s Risk functions, Lee developed the self-retained risk portfolio for the world’s largest fleet including captive insurance companies, claims administration, and agency operations. Lee was also responsible for Government Relations, Legal, Mergers and Acquisitions, Corporate Venture Capital, and Strategic Planning. Lee led acquisitions of fleet companies, technology companies, and adjacent businesses in excess of $2 billion. Enterprise also developed an active Corporate Venture fund in the emerging mobility sector. Lee attended the University of California, Santa Barbara and holds a BA in Business Economics and Accounting.
Erica currently serves as Senior Vice President and Practice Lead of the Private Equity Human Capital Risk practice at CAC Specialty, where she specializes in advising private equity clients on portfolio risk and mitigation strategies.
Mark Kaufman is the Founder and former Chief Executive Officer of Athletico Physical Therapy (“Athletico”) and has over 22 years of experience in the physical therapy industry. Mark has grown Athletico from a single location in Chicago in 1991 to a leading physical therapy provider in the Midwest with more than 500 locations throughout 12 states. Athletico offers physical and occupational therapy, athletic training and personal fitness services. Mark also served on the Board of Directors for Excel Rehabilitation Services and Michigan Rehabilitation Specialists, a former Shore Capital backed company.
Pat Kelly currently serves on the Board of Directors of Strongpoint Partners . Pat is a Senior Advisor at Brigade Capital Management, an alternative investment management firm that he founded and led as President and CEO.
Molly Kerr currently serves on the Board of Directors of Transformations Care Network. She is a Partner at Bain and Company where she is a product leader in the Performance Improvement practice, an active contributor in the healthcare practice and a member of Bain’s training and recruiting teams. Molly joined Bain in 1996 and has since worked in healthcare, consumer products and financial services. During her career at Bain, Molly has worked with clients to develop growth strategies, evaluate acquisition targets, redesign supply chain systems and implement large scale profit improvement programs. Molly is also leader of Bain’s Service Operations product suite where she focuses on full potential programs, cost reduction and major change programs.
Gulam Khan is a board member on Innovia Medical and AA Medical, two Shore Capital portfolio companies. He became the CEO/Co-Chairman of Cleveland-based medical device company U.S. Endoscopy in 2003 after joining the company in 2000. During his tenure as CEO, the company was recognized for several awards, including the Weatherhead 100 List of Fastest Growing Companies in Northeast Ohio (2003-2012), MDM Magazine’s 50 Medical Device Companies To Watch, and NorthCoast 99 Best Places To Work. In 2007, Gulam was honored as an Ernst & Young Entrepreneur of the Year Finalist for Northeast Ohio. In August 2012, U.S. Endoscopy was acquired by STERIS (NYSE: STE) for $270 million.
Larry Kloess serves on the Board of Directors of EyeSouth Partners, a realized Shore portfolio company. He is a co-founder of FKP Advisors. He also serves on the FCA Advisory Board and is a Special Operating Partner of FCA Venture Partners. Larry is a healthcare executive with over 35 years of leadership experience in hospital and physician group management. He retired from Hospital Corporation of America (HCA) in December, 2011, after 28 years of senior leadership responsibility, most recently serving as the CEO of Centennial Medical Center from 1998-2005, and then the President of HCA’s TriStar Division from 2005-2011, with operational responsibility for 20 HCA hospitals and 10 ambulatory surgery centers throughout Tennessee, Georgia, and Kentucky. Larry is board-certified in healthcare management, a Fellow in the American College of Healthcare Executives, and has been a licensed nursing home administrator.
Walt Knysz serves on the Board of Directors of Great Lakes Dental Partners, a Shore Capital portfolio company. He has long been involved in dentistry and dental management throughout his career. He was founder and CEO of Great Expressions Dental Centers (GEDC) for about twenty years, a dental practice management company that grew to over 150 affiliated dental offices in seven states.
Jan Knysz serves on the Board of Directors of Great Lakes Dental Partners, a Shore Capital portfolio company. Previously, Jan served as Chief Operating Officer of Great Expressions Dental Centers (GEDC), a dental practice management company that grew to over 150 affiliated dental offices in seven states.
Therus Kolff currently serves on the Board of Directors for Specialdocs Consultants. Therus is the Treasurer on the Board of Directors for EARTH University Foundation, formed to support the educational vision of Costa Rica-based EARTH University through generous gifts from the global community and other programs and initiatives. The Foundation is headquartered in Atlanta, GA.
Ted has over 20 years’ professional experience, most of which has been spent serving in executive capacities across at several companies. Ted currently serves as the Chief Executive Officer of Galleher, one of the largest flooring distributors in the United States. Prior to starting in his current role, Ted served as the President and Chief Executive Officer of Keyes Packaging, a leading provider of environmentally friendly protective packaging for the food and beverage industry. Ted worked closely with Richard Boos when Keyes Packaging was acquired by Arbor Investments in July of 2013. Ted has prior experience working with financial sponsors, previously serving as Chief Executive Officer of Plastimayd, a Private Equity-owned manufacturer of vinyl in-ground swimming pool liners and safety covers, for four years. We are excited about Ted’s packaging and distribution experience as he brings expertise and an extensive resume of optimizing, building and growing building small and mid-sized businesses.
Chris Krubert currently serves on the Board of Directors for Specialdocs Consultants. Chris was previously Chief Executive Officer of ApolloMD, a healthcare professional services firm consisting of over 2,500 healthcare professionals specializing in emergency medicine, anesthesia, radiology, and hospitalist medicine. From 2006 – 2013, Chris built ApolloMD into an industry leading multi-specialty physician services firm, having won Ernst & Young’s Entrepreneur of the Year in 2009 for his efforts. Chris is a Senior Scholar at Duke University's Fuqua School of Business and he is active at The University of Chicago's Booth School of Business Polsky Center for Entrepreneurial Studies. Additionally, Chris serves on the Board of Regents for Mercy Home for Boys & Girls.
Keith currently serves on the Board of Directors of Community Care Partners. Keith brings a wide range of operational and financial experience in the healthcare industry spanning over 30 years. As the former Chief Executive Officer of several healthcare companies, he has a unique client perspective as well as broad contacts within the industry, private equity and other financing sources.
George A. Leondis is President and Chief Executive Officer, and a member of the Board of Directors, of Argon Medical Devices, Inc. He has over 25 years of leadership experience in the medical device industry and is responsible for all strategic and functional areas of Argon’s business.
Todd has over thirty-six years of executive experience in the healthcare real estate industry. From 1994 to 2010, he served as Chairman and CEO of Lillibridge Healthcare Services.
Dan Lorimer currently serves on the Board of Directors of both Southern Veterinary Partners and Mission Veterinary Partners. Dan is a Partner, Medical Director and Board Member of BluePearl Veterinary Partners (“BluePearl”), the largest specialty veterinary hospital group in the U.S. Dan founded Michigan Veterinary Specialists, which he grew to five practices, and Georgia Veterinary Specialists, which has two locations, and merged those clinics with BluePearl in 2010. Dan is a board certified veterinary ophthalmologist and has been practicing veterinary medicine for more than 25 years. Dan has extensive experience with operations and business development in the veterinary sector and has many contacts throughout the industry.
Ron Malone is a Board of Directors Member at The Stepping Stones Group, a Shore Capital portfolio company. Ron has more than 30 years experience leading healthcare and human capital organizations. Currently Ron is a principal at Transpirus, which provides consulting and revenue cycle management outsource services for the home health and hospice industry. From 2002 to 2010, he was Chairman and CEO of Gentiva, the nation’s leading provider of comprehensive home healthcare and related services. At Gentiva, Ron developed industry leading compliance and employee training programs. Prior to Gentiva, Ron held various executive leadership positions with Olsten Staffing and Emery Worldwide. Additionally, Ron is a Director at Hill-Rom and Capital Senior Living, publicly traded healthcare services companies.
Currently, Tim previously served as a Director for Southern Veterinary Partners, a Shore Capital Portfolio Company based in Birmingham. Alabama. Tim is the Principal of Nashville Healthcare Investments. Previously, Mr. Martin was the Founder and CEO of Ambulatory Services of America’s family of companies, which included ASA, Radiation Oncology Services of America and Innovative Dialysis Systems. The company was sold to US Renal in 2013. Previously, Mr. Martin held roles as EVP and Chief Operating Officer of publicly traded Renal Care Group, (RCI) which sold to Fresenius in 2006. He is also a Principal of National Renal Care Holdings, and serves on Brown Brothers Harriman’s Healthcare Advisory Board.
Joe Matarese is the founder and Executive Chairman of Medicus Healthcare Solutions. Joe has over 20 years of experience in the Healthcare and Information Technology Services Industries. He founded Medicus in January of 2004 on the principle that there had to be a better way to deliver consulting and staffing services to healthcare clients. His innovative approach to providing physician staffing and operational consulting services to hospitals and clinics has revolutionized the industry. Today Medicus provides these services to clients across the United States.
Mr. Maurer serves as CEO of Shore Capital’s oral surgery platform investment, and as a Board Member for Southern Orthodontic Partners, Shore Capital's network of orthodontists and management support services.
Jim McCurry serves as a member of the Board of Directors of Florida Autism Center, a Shore Capital Portfolio Company. Jim most recently served as President and CEO of Pediatric Services of America (PSA Healthcare), a leading provider of in-home care for medically fragile children. Prior to PSA, Jim was Chairman, President, & CEO of PRGX Global, the world’s largest provider of recovery audit services. Jim is a former Partner at Bain & Company, the international management consulting firm and was co-founder and chairman of Babbage’s, Inc., a predecessor company of GameStop. He has served as a director of Interstate Hotels and Resorts and of Pacific Sunwear of California and was a member of the Board of Regents of Texas Women’s University.
Sean McEnroe serves on multiple equity backed, multi-site healthcare, start-up, and non-profit boards.
Chip served on the Sirona Infusion Board of Directors and has over 26 years of experience in the home infusion industry. Chip was the Founder, Chairman and CEO of Integrity Healthcare Services and Total Pharmaceutical Care. Chip’s most recent company, Integrity Healthcare, was sold to Priority Healthcare in July 2004. In addition to serving on the Sirona Board of Directors, Chip serves as a Senior Advisor to Shore Capital and helps to identify operating executives, source acquisitions, improve operations, and drive organic growth.
Dr. Medvec advises CEOs, senior leaders and Board members on critical decisions and high stakes negotiations including mergers, acquisitions, significant customer contracts, regulatory filings, and partnership agreements. Prior clients include many Fortune 100 companies as well as smaller growth-oriented organizations across a wide variety of industries including Microsoft, McKinsey, Johnson & Johnson, OMERS, American Securities, McDonalds, Pfizer, BlackRock, Amgen, BCG, and Omnicom Media Group.
Gene currently serves on the Board of Directors of SENTA and Together Women's Health. Gene most recently served as Chief Executive Officer and President of Beaumont Health, the largest healthcare system in southeast Michigan. He has previously held the positions of Chief Operating Officer, Executive Vice President, Senior Vice President, and Hospital Director. Gene joined Beaumont in 1971, working in a hospital laboratory. As CEO, Gene successfully oversaw the merger of Beaumont Health with Oakwood Healthcare Systems and Botsford Healthcare. He currently serves as the delegate for the AHA Regional Policy Board Region 5. He is a former member of the Michigan Health and Hospital Association Executive Committee and Board of Trustees, and a current member of the Greater Detroit Area Health Council Executive Committee and Board of Trustees, the Oakland County Michigan Medical Main Street Board, and the Detroit Regional Chamber Board of Directors. Gene draws from a deep background comprising of healthcare administration, business development, and operations.
<p>Wayne has over 35 years’ experience in the packaging industry experience across many roles, while always prioritizing a focus on product differentiation and profitable growth. Wayne is the former Chief Executive Officer of Trojan Lithograph Corporation, a leading designer and manufacturer of consumer packaging. Prior to his role at Trojan, Wayne held several C-suite roles including as the former President of Allpak Container and Allpak Container East and as the former Vice President of Business Development at Crown Packaging.</p>
Joe currently serves as Chief Business Officer at Great Lakes Caring, a home health, hospice care, and home medical equipment provider that serves more than 6,000 patients across Michigan, Indiana, and Ohio. Prior to his role at Great Lakes, Joe was an equity owner in Residential Home Health LLC, a small privately-owned Medicare certified home health care company in Michigan. Joe recruited, hired, trained and managed a group of over 25 sales professionals to build the company into the largest home health care agency in the state of Michigan, with over 450 full time employees. Joe completed and integrated the geographic expansion of Residential Home Health into Chicago with the acquisition of Edward Hospital Home Care, and grew that census from 89 upon transaction closing to a patient census of 275 in just 18 months.
Chryssy Moor is a Board Certified Behavior Analyst, a doctoral candidate, and the Founder of Florida Autism Center. Chryssy founded the Company in 2007 after providing in-home services in the Sanford area since 2005. Chryssy developed FAC’s mission, vision, and values and is responsible for the clinical direction of the Company and ensuring that therapy is implemented according to best-in-class standards. Chryssy’s primary interests are legislation concerning Early Intervention/Behavior Analysis and Autism Treatment and organizational strategy and management. In addition, Chryssy serves on the New Directions Provider Advisory Council. Chryssy received a Bachelor of Music in Music and Education with a minor in Psychology from Ohio Northern University and a Master of Science in Applied Behavior Analysis from Florida Institute of Technology.
Dr. Steven Morris serves on the Board of Directors of EyeSouth Partners, a realized Shore portfolio company, and SENTA, a Shore Capital Portfolio company. Dr. Morris is a clinical associate professor with the Emory University School of Medicine and currently serves as Managing Partner of Atlanta Gastroenterology Associates, which has over 40 locations and 10+ ASCs in the Atlanta, GA area. He initially joined the practice in 1978. Following his internship and residency at Emory University Affiliated Hospitals in Atlanta, Dr. Morris completed a fellowship in digestive diseases at the University of Miami. Dr. Morris is a member of numerous professional associations including the American College of Physicians, the American Medical Association, the American Gastroenterology Association, the Medical Association of Atlanta, the Medical Association of Georgia, and the Georgia Gastrointestinal Society. He is past president of the Georgia Gastrointestinal Society and previously served as chief of staff at Emory University Hospital Midtown Hospital.
Pat currently serves on the Board of Directors of Assembly Health. Pat is currently the President and CEO of Elmcroft Senior Living, a company which he founded that provides management services for senior living facilities. Prior to his role at Elmcroft, Pat served as President and CEO of Atria Senior Living, a large national provider of retirement, assisted living, and dementia care services. Pat draws from a deep background comprising of multi-location operations, senior living facility operations, and long-term care facility experience.
Michael currently serves on the Board of Directors of Assembly Health and H2O Care Partners. Michael is currently the COO of Symphony Post Acute Network, an integrated transitional care, post acute, and senior housing network. Prior to his role at Symphony, Michael served as COO of CRL Senior Living Communities, a leading owner/operator of private pay assisted living and memory care centers. Michael draws from a deep background comprising of multi-location operations, senior living facility operations, and long-term care facility experience.
Dr. Murphy is a Professor of Medical Imaging at the University of Toronto and an Interventional Neuroradiologist at Toronto Western hospital, Canada's largest neuroscience center. Dr. Murphy was the Director of Interventional Neuroradiology from 1998 to 2008. Prior to his time at Johns Hopkins, Dr. Murphy served as the Director of Research in the neuroradiology section of the Albany Medical College in New York. He is considered to be one of the most innovative specialists in the use of radiology guidance in the treatment of vascular brain and spine disorders. His research focuses on the use of imaging techniques to guide surgical intervention, particularly brain aneurysms and carotid artery disease.
Tim Murphy is a Board of Directors Member at Column Health, Shore Capital's second medication-assisted treatment platform investment. Tim currently serves as CEO of the Stepping Stones Group, a previous Shore Capital portfolio company that provides school and home-based ABA services. Stepping Stones is currently owned by Five Arrows Capital Partners and a Partner from Shore Capital, Ryan Kelley, currently serves as a board member. Tim previously served as President and Chief Executive Officer of Beacon Health Options and its predecessor companies from 2007 through 2017. Tim was instrumental in growing the company from $35 million to $2 billion in revenue in 2017, making Beacon the largest independent manager of behavioral health benefits in the United States. Before joining Beacon, Tim served as the Secretary of Health and Human Services for the Commonwealth of Massachusetts under Governor Mitt Romney. Preceding his service in the Romney Administration, Tim was a vice president in the investment banking division of JP Morgan. Tim serves as Senior Advisor to Beacon Health Options’ Board of Directors and as a board member for Addiction Campuses, a substance use disorder residential treatment facility company, based in Nashville, TN.
Edward Murphy is a Board of Directors Member at Behavioral Innovations, BrightView, and Column Health, Shore Capital's autism services and medication-assisted treatment platform investments. Edward most recently served as Executive Chairman of the Board of Directors of Civitas Solutions (f.k.a. the MENTOR Network), a publicly traded at home- and community-based behavioral health services provider with over 12,500 residential clients and 17,400 non-residential clients. Edward served as CEO of Civitas Solutions while the Company was owned by Madison Dearborn Partners and then Vestar Capital Partners. Prior to his role as Executive Chairman and CEO of Civitas, Edwardwas founder and CEO of Alliance Health and Human Services. In addition, Edward served as Commissioner of the Massachusetts Department of Youth Services and the Massachusetts Department of Mental Health, and the former Executive Director of the Massachusetts Health and Educational Facilities Authority.
Jim Myer serves on the Board of Directors of Great Lakes Dental Partners, a Shore Capital portfolio company. Most recently, he was the President and CFO of Kristo Orthodontics, an eleven location orthodontic practice headquartered in Eau Claire, Wisconsin.
Greg currently serves on the Board of Directors of Southern Orthodontic Partners and OMS360, Shore Capital Portfolio companies.” Greg is the Chief Executive Officer at Sunvera Group. Greg was previously President at Great Expressions Dental Centers (GEDC), a leading dental support organization in the United States. Greg led strategy surrounding the company’s continued commitment to providing high quality care to patients, as well as the organization’s ongoing growth. Greg was an integral member of Great Expressions’ executive team for nearly two decades and was vital in the company’s rapid growth. Greg served as GEDC’s Chief Operating Officer from 2013 – 2018, where he was responsible for oversight of the company’s offices, office processes, regional directors and staff development. He joined GEDC in 1999 as vice president of finance where he led overall financial operations and managed IT and accounts receivable departments and was subsequently promoted to CFO. During his tenure with GEDC, the organization added over 250 offices and increased the number of patients it serves to 120,000 per month.
Paul O'Connell is a board member of SCP Interventional Radiology, a realized Shore portfolio company. Paul serves as the President of B. Braun Interventional Systems, Inc. Starting in July 2001, he was the Vice President of the Vascular Interventional Products Group at B. Braun. From 1999 to 2001, he provided Marketing and Technical support consulting services to medical device companies. He was the Owner of Sablier from 1998 to 1999 where he developed new technologies for the treatment of thromboembolic diseases and for distal protection during carotid endarterectomy. From 1993 to 1998, Paul served as Vice-President and General Manager of the Vena Tech division of B. Braun Medical, a medical device business which he originally co-founded in 1988 and sold to B. Braun Medical in 1993. He has been a member of the Board of Directors of Vascular Solutions, Inc. since January 2002.
Edmund has over 25 years’ experience in various management and board roles in the food and beverage sector in both North America and Europe. Edmund served on the Board of Directors at Pineridge Bakery, a leading $225M revenue Canadian specialty bakery backed by Swander Pace Capital, which was acquired by ARYZTA in 2014 for ~$340M following significant growth through new customers, acquisitions and new products over a seven-year period. He currently serves as Chairman of O’Keeffes Group, an Irish retailer with pet, furniture and wine stores. In North America, over the last 24 years, Edmund served in a variety of roles for Cott Corporation, the world's largest producer of beverages on behalf of retailers, brand owners and distributors. Prior to this role, Edmund served as President of Royal Crown Cola International, a branded franchise beverage portfolio with bottlers across 64 countries.
Kevin Offel currently serves as the Lead Independent Director for Great Lakes Dental Partners. He also serves on the Board of Directors of Strongpoint Partners, Specialdocs Consultants and EyeSouth Partners, a realized Shore portfolio company.
Mitch Olan currently serves on the Board of Directors and as Lead Independent Director of OMS360.
Tom currently serves on the Board of Directors of OMS360, a Shore Capital Portfolio company. Tom is the Chief Executive Officer, as well as on the Board of Directors of Mavrik Dental Systems, a privately held company specializing in the development and commercialization of innovative in-office teeth whitening products. Prior to this, Tom held several positions, and ultimately was the President and General Manager of North America for Nobel Biocare, a world leader in the field of innovative implant-based dental restorations, from single-tooth to fully edentulous indications. Additionally, Tom was a Vice President of Sales and Marketing of Denar Corp, a Senior Product Manager of 3M Unitek, and a National Sales Training Manager of Ormco.
Garrett currently serves as VP of Finance, Retail Packaged Brands of Tyson Foods, where he is responsible for supporting Tyson Foods’ retail leadership team and providing key financial insights to drive the group’s strategic decisions. Prior to his current role, Garrett was in various finance positions at Jimmy Dean, Sara Lee, Van’s and Goose Island. Garrett has significant bakery experience through his various roles at Sara Lee Bakery for several years and served as Director of FP&A at Sara Lee. In addition, he spent over 4 years in a Corporate Development role for Sara Lee.
Greg Palmer is a member of the Board of Directors at The Stepping Stones Group, a Shore Capital portfolio company. Greg has more than 30 years of leadership experience. Currently Greg is a principal at Transpirus, which provides consulting and revenue cycle management outsource services for the home health and hospice industry. Greg became CEO of Remedy, a leading staffing firm, in 2001. At Remedy, he started the RemX specialty division and grew revenue to $100M. Over a five year period, Greg completed a major turn around and sale, resulting in significant shareholder value creation. Prior to Remedy, Greg was a senior vice president at Olsten Staffing.
As a senior executive with over 20 years of innovation experience in the CPG industry, Rocco has driven the development and launch of highly successful, award-winning products for companies like Procter & Gamble, PepsiCo, and Del Monte Foods (now Big Heart Pet Brands). Over the course of his career, Rocco has led critical technology innovations in ingredients, processes, packaging, and products. These innovations have yielded dozens of patents, competitively advantaged revenue growth, significant cost savings, and growing market share. Most recently, Rocco was recruited by a private equity group comprised of KKR, Vestar Capital Partners, and Centerview Capital to accelerate growth through innovation at Del Monte & Big Heart Pet Brands. Rocco played a critical role in the leadership of Big Heart’s rapid growth and eventual sale to JM Smucker and Del Monte Foods' sale to Del Monte Pacific. Prior to his time with Big Heart, Rocco spent 24 years in R&D and Innovation at PepsiCo and led the entire R&D function as SVP of R&D for Frito Lay World Wide.